Sampre Nutritions [SAMPRE] vs Triveni Engineering [TRIVENI] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sampre Nutritions Ltd. wins in 8 metrics, Triveni Engineering & Industries Ltd. wins in 11 metrics, with 0 ties. Triveni Engineering & Industries Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sampre Nutritions Ltd. | Triveni Engineering & Industries Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 151.31 | 29.85 | Triveni Engineering & Industries Ltd. |
| Price-to-Book Ratio | 1.66 | 2.97 | Sampre Nutritions Ltd. |
| Debt-to-Equity Ratio | 17.06 | 24.55 | Sampre Nutritions Ltd. |
| PEG Ratio | -0.84 | -0.06 | Triveni Engineering & Industries Ltd. |
| EV/EBITDA | -102.17 | 16.80 | Triveni Engineering & Industries Ltd. |
| Profit Margin (TTM) | -15.61% | 4.64% | Triveni Engineering & Industries Ltd. |
| Operating Margin (TTM) | 13.33% | 7.75% | Sampre Nutritions Ltd. |
| EBITDA Margin (TTM) | 13.33% | 7.75% | Sampre Nutritions Ltd. |
| Return on Equity | -9.54% | 7.70% | Triveni Engineering & Industries Ltd. |
| Return on Assets (TTM) | -6.65% | 3.90% | Triveni Engineering & Industries Ltd. |
| Free Cash Flow (TTM) | $-1.93M | $-4.06B | Sampre Nutritions Ltd. |
| Dividend Yield | N/A | 1.07% | N/A |
| 1-Year Return | 93.93% | -14.07% | Sampre Nutritions Ltd. |
| Price-to-Sales Ratio (TTM) | 4.51 | 1.43 | Triveni Engineering & Industries Ltd. |
| Enterprise Value | $2.08B | $98.55B | Triveni Engineering & Industries Ltd. |
| EV/Revenue Ratio | 5.77 | 1.54 | Triveni Engineering & Industries Ltd. |
| Gross Profit Margin (TTM) | 79.78% | 30.27% | Sampre Nutritions Ltd. |
| Revenue per Share (TTM) | $3 | $337 | Triveni Engineering & Industries Ltd. |
| Earnings per Share (Diluted) | $-1.13 | $13.99 | Triveni Engineering & Industries Ltd. |
| Beta (Stock Volatility) | -0.46 | 0.31 | Sampre Nutritions Ltd. |
Sampre Nutritions Ltd. vs Triveni Engineering & Industries Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sampre Nutritions Ltd. | -3.96% | 1.12% | -26.20% | -38.05% | -58.84% | -51.41% |
| Triveni Engineering & Industries Ltd. | 2.73% | -5.07% | -13.65% | -9.20% | 1.50% | -5.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sampre Nutritions Ltd. | 93.93% | -29.24% | 172.14% | 1.95% | 447.70% | 561.11% |
| Triveni Engineering & Industries Ltd. | -14.07% | 36.96% | 148.11% | 664.47% | 898.67% | 661.68% |
Performance & Financial Health Analysis: Sampre Nutritions Ltd. vs Triveni Engineering & Industries Ltd.
| Metric | SAMPRE | TRIVENI |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.63B | ₹91.45B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 1,225,218 | 625,475 |
| 90 Day Avg. Volume | 579,252 | 1,149,992 |
| Last Close | ₹12.12 | ₹372.10 |
| 52 Week Range | ₹5.76 - ₹42.33 | ₹317.55 - ₹445.50 |
| % from 52W High | -71.36% | -16.48% |
| All-Time High | ₹559.20 (Nov 11, 2025) | ₹536.00 (Dec 30, 2024) |
| % from All-Time High | -97.83% | -30.58% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.32% | 0.17% |
| Quarterly Earnings Growth | 0.32% | 0.75% |
| Financial Health | ||
| Profit Margin (TTM) | -0.16% | 0.05% |
| Operating Margin (TTM) | 0.13% | 0.08% |
| Return on Equity (TTM) | -0.10% | 0.08% |
| Debt to Equity (MRQ) | 17.06 | 24.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹11.20 | ₹140.62 |
| Cash per Share (MRQ) | ₹0.04 | ₹4.66 |
| Operating Cash Flow (TTM) | ₹-42,782,000 | ₹-934,800,000 |
| Levered Free Cash Flow (TTM) | ₹-76,723,000 | ₹2.43B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.07% |
| Last 12-Month Dividend | N/A | ₹4.00 |
Valuation & Enterprise Metrics Analysis: Sampre Nutritions Ltd. vs Triveni Engineering & Industries Ltd.
| Metric | SAMPRE (Apr 24, 2026) | TRIVENI (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 151.31 | 29.85 |
| Forward P/E | N/A | 25.31 |
| PEG Ratio | -0.84 | -0.06 |
| Price to Sales (TTM) | 4.51 | 1.43 |
| Price to Book (MRQ) | 1.66 | 2.97 |
| Market Capitalization | ||
| Market Capitalization | ₹1.63B | ₹91.45B |
| Enterprise Value | ₹2.08B | ₹98.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.77 | 1.54 |
| Enterprise to EBITDA | -102.17 | 16.80 |
| Risk & Other Metrics | ||
| Beta | -0.46 | 0.31 |
| Book Value per Share (MRQ) | ₹11.20 | ₹140.62 |
Financial Statements Comparison: Sampre Nutritions Ltd. vs Triveni Engineering & Industries Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SAMPRE (2025) | TRIVENI (2025) |
|---|---|---|
| Revenue/Sales | 251.24M | 56.62B |
| Cost of Goods Sold | 228.43M | 43.71B |
| COGS % of Revenue | 90.9% | 77.2% |
| Gross Profit | 22.81M | 12.91B |
| Gross Margin | 9.1% | 22.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -58.34M | 3.57B |
| Operating Margin | -23.2% | 6.3% |
| EBITDA | -38.57M | 5.29B |
| EBITDA Margin | -15.4% | 9.3% |
| Pre-Tax Income | -75.25M | 3.24B |
| Pre-Tax Income % of Revenue | -30.0% | 5.7% |
| Income Tax | 1.47M | 859.70M |
| Income Tax % of Revenue | 0.6% | 1.5% |
| Net Income (Profit) | -76.72M | 2.38B |
| Profit Margin | -30.5% | 4.2% |
Balance Sheet & Liquidity Metrics
| Metric | SAMPRE (2025) | TRIVENI (2025) |
|---|---|---|
| Cash & Equivalents | 2.32M | 460.80M |
| Total Current Assets | 154.75M | 36.22B |
| Total Current Assets % of Revenue | 61.6% | 64.0% |
| Total Current Liabilities | 132.17M | 24.82B |
| Total Current Liabilities % of Revenue | 52.6% | 43.8% |
| Long-Term Debt | 105.85M | 4.05B |
| Long-Term Debt % of Revenue | 42.1% | 7.2% |
| Total Shareholders Equity | 804.17M | 31.60B |
| Retained Earnings | -21.77M | 30.39B |
| Retained Earnings % of Revenue | -8.7% | 53.7% |
| Property, Plant & Equipment | 27.83M | 23.20B |
Cash Flow Statement Comparison
| Metric | SAMPRE (2025) | TRIVENI (2025) |
|---|---|---|
| Operating Cash Flow | -42.78M | -934.80M |
| Operating Cash Flow % of Revenue | -17.0% | -1.7% |
| Capital Expenditures | -2.77M | -2.98B |
| Free Cash Flow | -1.93M | -4.06B |
| FCF Margin | -0.8% | -7.2% |
| Debt Repayment | -16.92M | -1.36B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SAMPRE | TRIVENI |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 87.39M | 218.90M |
| Float Shares | 43.74M | 72.92M |
| % Held by Insiders | 44.91% | 66.71% |
| % Held by Institutions | 0.00% | 10.27% |
| % Held by Public | 55.09% | 23.02% |
Dividend Analysis & Yield Comparison: Sampre Nutritions Ltd. vs Triveni Engineering & Industries Ltd.
| Metric | SAMPRE | TRIVENI |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹4.00 |
| Last 12-Month Dividend Yield | N/A | 1.07% |
| 3-Year Avg Annual Dividend | N/A | ₹4.33 |
| 3-Year Avg Dividend Yield | N/A | 0.72% |
| 3-Year Total Dividends | N/A | ₹13.00 |
| Ex-Dividend Date | N/A | Feb 06, 2026 |